An international team has sequenced the genome of Schistosoma mansoni, a parasite that infects 200 million people in 76 countries through freshwater snails.
The US is not one of the affected countries because we don't have the snails that carry the Schistosoma mansoni parasite, though Americans at risk include those traveling in the Peace Corps, on business or for church missions. The new research is the largest genome sequencing of a parasite to date.
Knowing the genetic codes of Schistosoma mansoni will help researchers develop better medication for infections, a diagnostic field test and even a vaccine, said co-author Phil LoVerde, Ph.D., professor of biochemistry and pathology at the The University of Texas Health Science Center at San Antonio, who has studied the parasite and its close relatives for more than three decades. S. mansoni, a neglected tropical disease, ranks with malaria and tuberculosis as a major cause of disease worldwide.
No vaccine exists, and only one medication, praziquantel, is available. “It is the only treatment asset we have, and there is evidence from the field and the lab that resistance to it can develop,” LoVerde said. Now his group is trying to identify the genes responsible for drug resistance. Sequencing the genome “gets us a lot,” he said. “It opens a new door for development of better control regimens.”
Individuals in Africa contract the S. mansoni infection, known as schistosomiasis or “snail fever,” by coming into contact with freshwater that contains the infected snails. Ten percent of infected persons develop an enlarged liver or spleen, as the body encapsulates S. mansoni eggs that have been deposited by the adult worms living in their victims’ blood vessels. The disease is common among children who live in areas where the water is unsafe, sanitation is poor and basic health care is unavailable.
S. mansoni is classified as a helminth, a family of worms that includes roundworms, pinworms and tapeworms. S. mansoni male and female pairs produce 300 eggs a day, each of which can infect a freshwater snail that produces the infectious form of the parasite. When humans come into contact with freshwater that contains the infectious larvae, the larvae can burrow through unbroken skin and develop into an adult worm. The disease is caused by the egg stage.
S. mansoni is the first representative of the lophotrochozoa, a phylum of invertebrates, to have its genetic code cracked. Sequencing the flatworm’s genome will not only contribute to understanding the biology of the parasite, LoVerde said, but will offer insights into adaptation of animals, especially the development of a body pattern with bilateral symmetry and the development of tissues into organs.
The worms, a centimeter in length, can live five to 10 years on average in humans. The longest-lived worms were found in unsuspecting hosts 40 years after infection, Dr. LoVerde said.
“Every day of their lives, people are exposed to S. mansoni in areas where it is endemic,” he said. “Existing drugs don’t prevent reinfection, so people have repeat cases. With the sequencing of this helminth’s genome, we can develop better treatments at unprecedented speed.”
Knowing the genetic sequence should make it possible to identify the genes that are responsible for the severity of infections, and why some people seem to develop immunity to repeat infections while others do not, LoVerde said.
LoVerde regularly travels to Africa, South America and other areas of the world to obtain snails and human blood and tissue samples. His lab developed, and is testing, vaccine candidates in a baboon model as a prelude to human clinical trials. The lab team is attempting to identify the signal that male worms send to females for development and reproduction. Females need a constant signal to maintain these processes.
The team also seeks to identify genes that enable the parasite to take advantage of human signals in order to develop.
Co-authors on the Nature paper are from U.S. and international laboratories, including the Institute for Genomic Research, Rockville, Md.; the University of Maryland, College Park; the University of California, San Francisco; Iowa State University; the Wellcome Trust Sanger Institute, Hinxton, U.K.; and the University of York, York, U.K.
By taking advantage of the genome sequence information, LoVerde, in collaboration with Timothy J.C. Anderson, Ph.D., of the genetics department at the Southwest Foundation for Biomedical Research in San Antonio, and Charles D. Criscione, Ph.D., of the biology department at Texas A&M University, produced the first microsatellite-based genetic linkage map for S. mansoni, just published in BioMed Central’s open access journal Genome Biology. This map represents another tool for researchers. Anderson and Criscione are not co-authors on the Nature article.
The U.S. portion of the genome sequencing project was supported by the National Institute of Allergy and Infectious Diseases, the John E. Fogarty International Center for Advanced Study in the Health Sciences, the Burroughs Wellcome Fund and the Tropical Disease Research Program of the World Health Organization.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- What Lies Beneath West Antarctica?
- Genetic Variant May Help Explain Why Labradors Are Prone To Obesity
- Early Warning: Current Japanese Encephalitis Vaccine Might Not Protect
- Mimicking The Ingenuity Of Nature
- Nanoparticles Hold Promise As Double-edged Sword Against Genital Herpes
- One Third Of Antibiotic Prescriptions Unnecessary
- Planet Nine: A World That Shouldn't Exist
- "It is good to see that Current Japanese Encephalitis Vaccine Might Not Protect. thank you for sharing..."
- "Your post are getting funnier by the minute. Here's the joke: What could be more Ivory Tower than..."
- "What actual science are you talking about? All I've seen so far, is a bunch of talking points from..."
- "The reason I feel compelled to use a different name is due to the difference in the topology You..."
- "Please email me, I want to know every bit of knowledge you can provide. I've got so many questions...."